Management Team

//Management Team
Management Team 2017-09-05T17:30:12+00:00

Our Management Team

President and CEO

Peter has 20+ years of sales and marketing experience in the medical device industry at ACS, Origin MedSystems, EndoVascular Technologies, and Guidant. Peter has worked as a sales representative, managed international distribution networks, launched products, and lead strategic initiatives. He holds a B.S. degree in chemical engineering from the University of Southern California and an MBA from Harvard University.

Chief Operating Officer

For over 18 years, Rick has been researching, developing and marketing medical devices. His entire career has been focused on early stage start-ups such as EndoVascular Technologies (25th employee) and CryoVascular Systems (1st employee). Rick was part of the first group to develop a cryoballoon. He holds a B.S. in textile engineering from North Carolina State University and is a named inventor on over 20 patents.

Director of R&D

Pat has 15+ years of R&D and project management experience in the medical device industry. He has been successful at early stage device start ups and at large multinational organizations. For 6 years, he has been innovating in the emerging cryoballoon technology area. He has worked in interventional cardiology, peripheral vascular, interventional pulmonology, and gastroenterology. Pat has served at Nitinol Devices & Components (NDC), Guidant and PneumRx. He earned a B.S. in mechanical engineering from Cal Poly San Luis Obispo, and an M.S. in engineering management from Santa Clara University. Pat is a named inventor on over 18 patents.

Director of Clinical Research

Marcia has 20+ years’ experience in clinical research in the US, Europe and Australia. She was born in Canada and has lived and worked in The Netherlands, Japan, and US. Marcia began her career as a nurse and has since worked as a Clinical Director for several medical device companies. Her career has been marked by many firsts including the first PMA of an endo AAA device, the first carotid stent with embolic protection, and the first in-office sinuplasty.

Vice President of Sales

Ryan Brennan is senior-level professional with more than 14 years of sales and sales management experience in the medical device industry. He has worked with leading companies to bring advanced technology to physicians, previously serving in key roles at Covidien, BARRX Medical and Johnson & Johnson. Ryan has an impressive track record of success – consistently exceeding sales quotas, implementing effective sales strategies and teams, boosting performance ratings, and introducing core initiatives to promote sustainable growth. Ryan received the Covidien Presidents’ Club award five consecutive years, and has also been named “Territory Manager of the Year,” “Regional Manager of the Year,” and “Rookie of the Year” during his career.

Vice President – Europe

Quentin Manley is a sales and marketing executive in the healthcare sector, with key experience in medical devices and technology. He has extensive experience creating high performing teams, devising successful go-to-market strategies, driving business models and surpassing growth and sales targets. Quentin specializes in the commercialization of novel medical devices in Europe, and he has managed sales and marketing initiatives in the United States, Middle East and Africa. Quentin has launched more than 20 significant new medical products across multiple geographies in the fields of pharmaceuticals, wound care, sutures, hernia repair and women’s health. Quentin spent more than 20 years at Johnson & Johnson, leading a variety of global marketing strategies.

Vice President of Finance

Linda is a financial professional with more than 35 years of experience in both the public and private sectors. Linda most recently served as director of finance for OptiMedica Corporation, a venture-backed company in ophthalmology that was successfully acquired by Abbott Labs in 2013. Prior to OptiMedica, Linda was director of finance at Guidant Corporation and its successor, Abbott Labs, for 14 years. At Guidant, Linda participated in activities from the Eli Lilly spin-off to pre-IPO activities leading to its $27 billion acquisition by Abbott Labs/Boston Scientific. Linda began her career in public accounting at Arthur Young & Co.